HemOncKB: Anticancer Drugs and Regimens in OMOP CDM Format

HemOncKB provides standardized data and metadata for systemic anticancer drugs and regimens, maintained by Jeremy Warner MD since May 2019. The dataset utilizes the OMOP Common Data Model (CDM) format for core tables and includes ancillary tables for complex oncological data structures. Updates are released approximately quarterly to reflect current clinical knowledge and administrative metadata.

Use Cases

• Mapping local oncology drug data to standardized OMOP concepts
• Analyzing systemic anticancer regimens using the provided metadata
• Integrating complex oncological structures into clinical databases via ancillary tables

Strengths

• Adheres to OMOP Common Data Model (CDM) standards
• Quarterly update cycle maintained for over 6 years
• Includes ancillary tables for complex data structures not easily represented in standard OMOP

Limitations

• Specific column names and row counts are not provided in the source metadata
• Requires domain expertise in OMOP CDM for effective utilization

Provenance

Source

Jeremy Warner MD, MS via HemOnc Dataverse

Time Range

2019-2026

Freshness

Updated approximately quarterly since May 2019.